| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |